Endometrial Cancer Treatment Market Pipeline Analysis, Share, Growth and Forecast to 2023

The global endometrial cancer treatment market is expected to witness growth due to unmet need of treatment, technological advancement in cancer therapeutics and diagnostic test, rising prevalence of cancer, and sedentary lifestyle of women. In addition, increasing awareness about the uterine diseases and the available therapies and increasing healthcare expenditure is also driving the growth of global endometrial cancer treatment market.

Explore Full Report at: https://www.psmarketresearch.com/market-analysis/endometrial-cancer-treatment-market

Endometrial cancer is an abnormal growth of uterus, in which inner lining of the uterus known as endometrium got affected. The American Cancer Society estimated that in year 2016, about 60,050 new cases of endometrial cancer would be diagnosed in the U.S. and about 10,470 women would die from cancers of the uterine body. The sign and symptoms of endometrial cancer is abnormal vaginal bleeding. It is most often diagnosed by pelvic ultrasound and transvaginal ultrasound. An endometrial biopsy is also preferred in postmenopausal women with endometrial cancer.

Geographically, North America is expected to be the largest market for endometrial cancer treatment owing to the favorable healthcare infrastructure and government initiatives, increasing number of research and development activities, and high prevalence of endometrial cancer. The U.S. contributed largest revenue to the North American endometrial cancer treatment market and it is expected to remain the largest market globally, during the forecast period.


Request for Table of Content at: https://www.psmarketresearch.com/market-analysis/endometrial-cancer-treatment-market/toc-sample

Some of the key players operating in the global market are Bristol-Myers Squibb Company, Merck & Co., Inc., Ariad Pharmaceuticals Inc., GlaxoSmithKline plc, Novartis AG, Sanofi, Eisai Co., Ltd., Exelixis, Inc., F. Hoffmann-La Roche AG, and Abbott Laboratories.